(Q46688573)

24 December 2017

title

Perioperative chemotherapy for resectable hepatic metastases (English)

1 reference

24 December 2017

1 reference

Scott Kopetz

1

1 reference

24 December 2017

Jean-Nicolas Vauthey

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

24 December 2017

published in

The Lancet

1 reference

24 December 2017

volume

371

1 reference

24 December 2017

issue

9617

1 reference

24 December 2017

page(s)

963-965

1 reference

24 December 2017

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960429-8

7 January 2021

10.1016/S0140-6736(08)60429-8

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18358910

1 reference

24 December 2017